reports
Praxis Precision Medicines to Participate in Upcoming Investor Confere...
Praxis Precision Medicines to Participate in Upcoming Investor Conferences BOSTON, May 17, 2024 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will be participating in three upcoming conferences. Praxis management will participate in a fireside chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference, taking place in New York, NY at the NASDAQ...
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise
Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise Pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 are potent, oral inhibitors with potential best-in-class profiles in RASm solid tumors Pipeline prioritization and workforce restructuring sharpens focus on programs targeting the highest unmet needs and with highest probability of success Priced concurrent $160 million equity offering Erasca to host conference call and webcast Friday, May 17, 2024 at 8:30 am ET SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-...
Erasca Announces Pricing of Underwritten Offering of Common Stock
Erasca Announces Pricing of Underwritten Offering of Common Stock SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of an underwritten offering of 86,486,486 shares of its common stock at a price of $1.85 per share. All of the shares to be sold in the offering are to be sold by Erasca. The gross proceeds to Erasca from the offering, before deducting the underwriting dis...
Hudson Pacific Properties Inc: 1 director
A director at Hudson Pacific Properties Inc sold 127,918 shares at 5.720USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth...
Amwell CEO Roy Schoenberg to Speak at Stanford Disability & Telehealth Conference Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Boston, May 16, 2024 (GLOBE NEWSWIRE) -- ® (NYSE: AMWL), a leader in hybrid care enablement, today announced its Co-CEO and President, Roy Schoenberg, M.D., M.P.H., will speak at the at 12:15 PST on Saturday, May 18. The virtual conference explores barriers to telehealth enhancement for those with disabilities and the innovative solutions underway to advance hea...
PubMatic to Participate at Upcoming Investor Summit
PubMatic to Participate at Upcoming Investor Summit NO-HEADQUARTERS/REDWOOD CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- PubMatic, Inc. (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced that members of its management team are scheduled to participate at an upcoming investor summit. Details for the event are as follows: Evercore ISI 3rd Annual Nothing But Net Internet Summit in New York on Wednesday May 29, 2024. About PubMatic PubMatic (Nasdaq: PUBM) is an independent technology company maximizing custome...
Kohl’s Declares Quarterly Dividend
MENOMONEE FALLS, Wis.--(BUSINESS WIRE)-- The Board of Directors of Kohl’s Corporation (NYSE:KSS) today declared a regular quarterly dividend of $0.50 per share on the Company’s common stock. The dividend is payable June 26, 2024, to shareholders of record at the close of business on June 12, 2024. About Kohl’s Kohl’s (NYSE: KSS) is a leading omnichannel retailer built on a foundation that combines great brands, incredible value and convenience for our customers. Kohl's serves millions of families in our more than 1,100 stores in 49 states, online at , and through our Kohl's App. For a list...
Oncocyte Reports First Quarter 2024 Financial Results
Oncocyte Reports First Quarter 2024 Financial Results Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc.On track to ship research use only (RUO) GraftAssure™ transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD kits are under development for FDA submission....
Kohl’s Corporation Holds Annual Shareholders Meeting
MENOMONEE FALLS, Wis.--(BUSINESS WIRE)-- Kohl’s Corporation (NYSE:KSS) (“Kohl’s” or the “Company”) today held its annual shareholders meeting. Following are the preliminary results for the five proposals voted upon by shareholders: Kohl’s shareholders elected Wendy Arlin, Michael J. Bender, Yael Cosset, Christine Day, H. Charles Floyd, Thomas A. Kingsbury, Robbin Mitchell, Jonas Prising, John E. Schlifske, Adrianne Shapira, and Adolfo Villagomez to the board of directors for one-year terms, with an average vote in favor of more than 96 percent of the votes cast; The advisory vote to appr...
Blink Charging Selected as an Official Electric Vehicle Charger and Ne...
Blink Charging Selected as an Official Electric Vehicle Charger and Network Services Provider for State of New York Blink chosen as one of the EV charging providers designated to provide expanded charging infrastructure and support a more sustainable future for the state. Bowie, Md., May 14, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global manufacturer, owner, operator and provider of electric vehicle (EV) charging equipment and services, has announced it has secured a contract as one of the official EV charging providers for the state of New York. ...
Barnwell Industries, Inc. Reports Results for its Second Quarter Ended...
Barnwell Industries, Inc. Reports Results for its Second Quarter Ended March 31, 2024 Production Increases for All Products Continued Reduction in General and Administrative Expenses HONOLULU, May 14, 2024 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE American: BRN) today reported financial results for its second fiscal quarter ended March 31, 2024. For the quarter, the Company had revenue of $5,774,000 and a net loss of $1,772,000, $0.18 per share. In the three months ended March 31, 2023, the Company reported quarterly revenue of $5,239,000 and a net loss of $1,237,000, $0.12 pe...
Oncocyte to Announce First Quarter 2024 Financial Results
Oncocyte to Announce First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties may access the l...
- Laura Chico
Praxis Precision Medicines Provides Corporate Update and Reports First...
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results Plans to initiate two efficacy studies investigating PRAX-628 in focal onset seizures in the second half of 2024 and first half of 2025, respectively Continued strong recruitment for the pivotal Essential3 trials in Essential Tremor (ET), with over 50,000 pre-screening forms and over 7,000 referrals received to date that meet pre-qualifying eligibility criteria; topline results expected in the second half of 2024 Randomization in PRAX-562 Phase 2 EMBOLD study completed in pediatric pati...
Praxis Precision Medicines to Report First Quarter 2024 Financial Resu...
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 BOSTON, May 10, 2024 (GLOBE NEWSWIRE) -- , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will report financial results for the first quarter 2024 on Monday, May 13, 2024, before the U.S. financial markets open. About Praxis Praxis Precision Medicines is a clinical-stage biopharmaceutical...
BLINK CHARGING ANNOUNCES FIRST QUARTER REVENUE GROWTH OF 73% TO $37.6 ...
BLINK CHARGING ANNOUNCES FIRST QUARTER REVENUE GROWTH OF 73% TO $37.6 MILLION AND GROSS MARGIN OF 36% ●First quarter 2024 total revenues increased 73% to $37.6 million compared to $21.7 million in first quarter of 2023 ●68% increase in product revenues to $27.5 million in first quarter of 2024 compared to $16.4 million in first quarter of 2023 ●72% increase in service revenues to $8.2 million in first quarter of 2024 compared to $4.8 million in first quarter 2023 ●195% increase in gross profit to $13.4 million in first quarter of 2024 compared to $4.5 million in first quarter of 2023 ●36% ...
Stifel to Sponsor the Tewaaraton Award, Honoring the Nation’s Top Coll...
Stifel to Sponsor the Tewaaraton Award, Honoring the Nation’s Top College Lacrosse Players ST. LOUIS, May 09, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that it has entered into a multiyear agreement to serve as presenting sponsor of The Tewaaraton Award, recognized as the preeminent lacrosse award and given annually to the nation’s top male and female college lacrosse players. The Tewaaraton Award is the latest in Stifel’s growing list of sports partnerships, which also includes the Haskins and Annika Awards honoring the top male and female college golfer...
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Pref...
Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend ST. LOUIS, May 08, 2024 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.42 per share, payable June 17, 2024, to shareholders of record at the close of business on June 3, 2024. The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), 6.125% Non-Cumulat...
Erasca Reports First Quarter 2024 Business Updates and Financial Resul...
Erasca Reports First Quarter 2024 Business Updates and Financial Results Median OS of 13-14 months for naporafenib plus trametinib in pooled analysis of patients with NRASm melanoma Strengthened balance sheet with private placement financing from high-quality new and existing healthcare-focused investors Pro forma cash, cash equivalents, and marketable securities of $334 million is expected to fund operations into H2 2026 SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, an...
Inozyme Pharma to Participate at the Bank of America Securities 2024 H...
Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Doug Treco, Ph.D., CEO and Chairman of Inozyme, will participate in a fireside chat at the Bank of America Securities 2024 Health Care Conference on Wednesday, May 15, 2024 from 6:40-7:10pm ET / 3:40-4:10pm PT. A live webcast of the firesi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.